Study of a Triple Combination Therapy, DTRM-555, in Patients With R/R CLL or R/R Non-Hodgkin's Lymphomas
Zhejiang DTRM Biopharma
Zhejiang DTRM Biopharma
Celgene
Incyte Corporation
University of Michigan Rogel Cancer Center
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
Barbara Ann Karmanos Cancer Institute
Alliance for Clinical Trials in Oncology
Baylor College of Medicine
City of Hope Medical Center
Ariad Pharmaceuticals
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Memorial Sloan Kettering Cancer Center